Companies

Aclaris Therapeutics, Inc. (ACRS) SEC filings

CIK 0001557746 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)7.8 M31.2 M29.8 M
Net income (USD)-86.9 M-51.0 M
Diluted EPS (USD/shares)-0.53-1.27-1.33

Latest filings

FiledFormDescriptionPeriod
2026-09-21SCHEDULE 13GSCHEDULE 13G
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-068-K8-K items 1.01,9.012026-08-06
2026-08-06S-3ASRS-3ASR
2026-08-0610-Q10-Q2026-06-30
2026-08-068-K8-K items 2.02,9.012026-08-06
2026-08-04442026-08-01
2026-06-08442026-06-04
2026-06-08442026-06-04
2026-06-08442026-06-04
2026-06-08442026-06-04
2026-06-08442026-06-04
2026-06-08442026-06-04
2026-06-048-K8-K items 5.072026-06-04
2026-05-12SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-0710-Q10-Q2026-03-31
2026-05-078-K8-K items 2.02,9.012026-05-07
2026-05-05442026-05-01
2026-04-288-K8-K items 7.01,8.01,9.012026-04-28
2026-04-27442026-04-27
2026-04-27SCHEDULE 13G/ASCHEDULE 13G/A
2026-04-23ARSARS2025-12-31
2026-04-23DEFA14ADEFA14A
2026-04-23DEF 14ADEF 14A2026-06-04
2026-04-07SCHEDULE 13GSCHEDULE 13G

Forms on file (last 1,000): 4 377, 8-K 151, SC 13G/A 65, 3 35, 10-Q 33, SC 13G 33, 424B5 14, SCHEDULE 13G/A 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ACRS (0.002 USD), /gw/filings/filings?ticker=ACRS&form=8-K, /gw/filings/facts?ticker=ACRS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange